1,847
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma

, , , , , , , , , & show all
Pages 1088-1101 | Received 16 Jan 2018, Accepted 20 Feb 2018, Published online: 27 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jingjing Yan, Weidong Fei, Qianqian Song, Yao Zhu, Na Bu, Li Wang, Mengdan Zhao & Xiaoling Zheng. (2022) Cell membrane-camouflaged PLGA biomimetic system for diverse biomedical application. Drug Delivery 29:1, pages 2296-2319.
Read now
Siyu Wang, Yiwei Wang, Kai Jin, Bo Zhang, Shaojun Peng, Amit Kumar Nayak & Zhiqing Pang. (2022) Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics. Expert Opinion on Drug Delivery 19:8, pages 965-984.
Read now

Articles from other publishers (19)

Maria Urbanova, Marina Cihova, Verona Buocikova, Jan Slopovsky, Peter Dubovan, Daniel Pindak, Miroslav Tomas, Laura García-Bermejo, Mercedes Rodríguez-Garrote, Julie Earl, Yvonne Kohl, Agapi Kataki, Maria Dusinska, Bruno SainzJr.Jr., Bozena Smolkova & Alena Gabelova. (2023) Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival. Biomedicine & Pharmacotherapy 165, pages 115179.
Crossref
Muhammad Akmal Raheem, Muhammad Ajwad Rahim, Ijaz Gul, Xiaoyun Zhong, Chufan Xiao, Haihui Zhang, Jiazhang Wei, Qian He, Muhammad Hassan, Can Yang Zhang, Dongmei Yu, Vijay Pandey, Ke Du, Runming Wang, Sanyang Han, Yuxing Han & Peiwu Qin. (2023) Advances in nanoparticles-based approaches in cancer theranostics. OpenNano 12, pages 100152.
Crossref
Zhiqiang Luo, Lingyu Sun, Feika Bian, Yu Wang, Yunru Yu, Zhuxiao Gu & Yuanjin Zhao. (2022) Erythrocyte‐Inspired Functional Materials for Biomedical Applications. Advanced Science 10:6.
Crossref
K. Laxmi Swetha, Kavya Sree Maravajjala, Shyh-Dar Li, Manu Smriti Singh & Aniruddha Roy. (2022) Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation. Drug Delivery and Translational Research 13:1, pages 105-134.
Crossref
Nan Zhang, Jing Li, Wenxia Gao, Wangwei Zhu, Jianqin Yan, Ziyun He, Li Li, Fang Wu, Yuji Pu & Bin He. (2022) Co-Delivery of Doxorubicin and Anti-PD-L1 Peptide in Lipid/PLGA Nanocomplexes for the Chemo-Immunotherapy of Cancer. Molecular Pharmaceutics 19:9, pages 3439-3449.
Crossref
Vahideh Mohammadzadeh, Niloufar Rahiman, Seyedeh Maryam Hosseinikhah, Mahmood Barani, Abbas Rahdar, Mahmoud Reza Jaafari, Saman Sargazi, Mohammad Reza Zirak, Sadanand Pandey, Rahul Bhattacharjee, Ashish Kumar Gupta, Vijay Kumar Thakur, Belay Zeleke Sibuh & Piyush Kumar Gupta. (2022) Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update. Journal of Drug Delivery Science and Technology 73, pages 103459.
Crossref
Riccardo Rampado, Paolo Caliceti & Marco Agostini. (2022) Latest Advances in Biomimetic Cell Membrane-Coated and Membrane-Derived Nanovectors for Biomedical Applications. Nanomaterials 12:9, pages 1543.
Crossref
Yige Fu, Aishwarya L. Saraswat, Jasmin Monpara & Ketan Patel. (2022) Stromal disruption facilitating invasion of a ‘nano-arsenal’ into the solid tumor. Drug Discovery Today 27:4, pages 1132-1141.
Crossref
Deepa Mundekkad & William C. Cho. (2022) Nanoparticles in Clinical Translation for Cancer Therapy. International Journal of Molecular Sciences 23:3, pages 1685.
Crossref
Ming Jia, Dan Zhang, Chunxiang Zhang & Chunhong Li. (2021) Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy. Journal of Nanobiotechnology 19:1.
Crossref
Marischa Elveny, Afrasyab Khan, Ali Taghvaie Nakhjiri & Ahmad B. Albadarin. (2021) A state-of-the-art review on the application of various pharmaceutical nanoparticles as a promising technology in cancer treatment. Arabian Journal of Chemistry 14:10, pages 103352.
Crossref
Sushant Prajapati, Taylor Hinchliffe, Vinay Roy, Nimit Shah, Caroline N. Jones & Girgis Obaid. (2021) Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines. Pharmaceutics 13:6, pages 786.
Crossref
Minghai Zhang, Shanshan Cheng, Yue Jin, Nan Zhang & Yu Wang. (2021) Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics. Clinical and Translational Medicine 11:2.
Crossref
Zeeshan Javed, Muhammad Javed Iqbal, Amna Rasheed, Haleema Sadia, Shahid Raza, Asma Irshad, Wojciech Koch, Wirginia Kukula-Koch, Anna Głowniak-Lipa, William C. Cho & Javad Sharifi-Rad. (2021) Regulation of Hedgehog Signaling by miRNAs and Nanoformulations: A Possible Therapeutic Solution for Colorectal Cancer. Frontiers in Oncology 10.
Crossref
Adrija Jha, Ajinkya Nitin Nikam, Sanjay Kulkarni, Sadhana P Mutalik, Abhijeet Pandey, Manasa Hegde, Bola Sadashiva Satish Rao & Srinivas Mutalik. (2021) Biomimetic nanoarchitecturing: A disguised attack on cancer cells. Journal of Controlled Release 329, pages 413-433.
Crossref
Rujing Chen, Leaf Huang & Kaili Hu. (2020) Natural products remodel cancer-associated fibroblasts in desmoplastic tumors. Acta Pharmaceutica Sinica B 10:11, pages 2140-2155.
Crossref
D. M. Valcourt, M. N. Dang, J. Wang & E. S. Day. (2019) Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer. Annals of Biomedical Engineering 48:7, pages 1864-1884.
Crossref
Xiaotian Xie, Haijun Wang, Gareth R. Williams, Yanbo Yang, Yongli Zheng, Junzi Wu & Li-Min Zhu. (2019) Erythrocyte Membrane Cloaked Curcumin-Loaded Nanoparticles for Enhanced Chemotherapy. Pharmaceutics 11:9, pages 429.
Crossref
Ridhima Wadhwa, Taru Aggarwal, Noopur Thapliyal, Ashutosh Kumar, Priya, Pooja Yadav, Vandana Kumari, Boda Sai Charan Reddy, Pranjal Chandra & Pawan Kumar Maurya. (2019) Red blood cells as an efficient in vitro model for evaluating the efficacy of metallic nanoparticles. 3 Biotech 9:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.